There is now a substantial body of evidence to suggest thatincreased levels of serum ICAM-1 are associated with the occurrence of atherosclerosis, myocardial infarction, peripheral artery disease and diabetes mellitus type 2 [4][6][8][13][14]. Here, ICAM1 is linked to diabetes mellitus.